COVID-19 Pneumonia in a Patient in Her Seventies that Improved without Antiviral Drug Treatment： A Case Study

DOI Web Site Web Site 7 References
  • MIYAZAWA Yuri
    Department of Hematology, Gunma University Graduate School of Medicine
  • YANAGISAWA Kunio
    Infection Control and Prevention Center, Gunma University Hospital
  • OGAWA Yoshiyuki
    Department of Hematology, Gunma University Graduate School of Medicine
  • KOISO Hiromi
    Infection Control and Prevention Center, Gunma University Hospital
  • TOKUE Yutaka
    Infection Control and Prevention Center, Gunma University Hospital
  • HANDA Hiroshi
    Department of Hematology, Gunma University Graduate School of Medicine

Bibliographic Information

Other Title
  • 無治療で改善した70 代のCOVID-19 肺炎の1 例
  • 症例 無治療で改善した70代のCOVID-19肺炎の1例
  • ショウレイ ムチリョウ デ カイゼン シタ 70ダイ ノ COVID-19 ハイエン ノ 1レイ

Search this article

Abstract

<p>As no specific therapeutic agents have been established yet for coronavirus disease 2019 (COVID-19),the illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), symptomatic therapy is the mainstay of treatment. Although the “Concept of antiviral treatment for COVID-19, First edition” published by the Japanese Association for Infectious Diseases recommends the use of antiviral medication for infected individuals over the age of 50 years, we have documented the case of a 73-year-old woman with COVID-19 pneumonia who improved without antiviral medication. The patient became infected with SARS-CoV-2 on the cruise ship, Diamond Princess, and first tested positive for SARS-CoV-2, by the RT-PCR test, on February 15, 2020. She was admitted to another hospital with fever and pneumonia on February 16, and on February, the pneumonia worsened in severity, she was transferred to our hospital. However, her condition improved spontaneously within a few days, without any antiviral medication. This report is very valuable for documenting the natural history of COVID-19 pneumonia and can be considered as a reference case for formulating strategies for antiviral drug administration for COVID-19 patients in the future.</p>

Journal

  • Kansenshogaku Zasshi

    Kansenshogaku Zasshi 94 (4), 568-572, 2020-07-20

    The Japanese Association for Infectious Diseases

References(7)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top